REGENXBIO Inc

RGNXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$7.53

Today

-4.0%

YTD

-47.6%

About

REGENXBIO Inc is a well-known figure in the global biotech sphere committed to the discovery, development and commercialisation of innovative therapies. Operating on an international scale, the company uses next-generation technologies for addressing severe medical conditions. Positioned within the biotechnology and healthcare sectors, REGENXBIO harnesses proprietary NAV technology to develop therapies for genetic and rare diseases along with retinal, neuromuscular diseases and neurodegenerative disorders. Although it stands as an independent entity, the firm has collaborations in place with leading pharmaceutical companies to expand its therapeutic touch. Monitor the RGNX share price on your eToro watchlist.

Price chart

Closing price history for RGNX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.05

P/S (TTM)2.36

P/B (TTM)5.86

Market cap$512.26M

Cap tierSmall-cap

Industry avg P/E-7.28

Profitability

Gross margin77.57%

EBIT margin-94.08%

Net margin21.02%

ROE-137.63%

ROA-40.60%

Earnings & Revenue

Revenue (TTM)$174.48M

Revenue growth (1Y)+12.0%

EPS (TTM)-$3.79

Free cash flow$-249.67M

Total debt$250.46M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.73

Employees371

Next earnings5 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.